Furthermore, results of the bc-GenExMiner database demonstrated that increased CDH4/12/13 expressions were associated with basal-like breast cancer, and increased CDH1/2/11 expressions suggested a high SBR grade status in patients. Here, CDH1 is linked to breast cancer.